Sonova Holding (OTCMKTS:SONVY) Receives Consensus Recommendation of “Hold” from Brokerages

Sonova Holding (OTCMKTS:SONVY) has been given an average recommendation of “Hold” by the eight ratings firms that are presently covering the stock, MarketBeat Ratings reports. Two research analysts have rated the stock with a sell recommendation, four have assigned a hold recommendation, one has issued a buy recommendation and one has assigned a strong buy recommendation to the company.

SONVY has been the topic of a number of recent research reports. Royal Bank Of Canada upgraded shares of Sonova to a “moderate buy” rating in a report on Tuesday, November 18th. Zacks Research raised Sonova from a “strong sell” rating to a “hold” rating in a research report on Monday, February 9th.

Sonova Stock Up 1.4%

OTCMKTS:SONVY opened at $50.76 on Monday. Sonova has a one year low of $47.55 and a one year high of $68.76. The company has a current ratio of 1.24, a quick ratio of 0.91 and a debt-to-equity ratio of 0.51. The firm’s 50 day simple moving average is $53.02 and its 200 day simple moving average is $54.15.

About Sonova

Sonova AG (OTCMKTS:SONVY) is a Switzerland-based provider of hearing care solutions, headquartered in Stäfa. The company designs, develops, manufactures and distributes a range of audiological products and related services aimed at improving hearing and communication for people with hearing loss. Its portfolio spans behind-the-ear and in-the-ear hearing instruments, wireless accessories and software solutions that enable connectivity with consumer devices and audiological fittings.

Sonova markets its products under several well-known brands, including Phonak and Unitron for hearing aids, and it is also associated with Advanced Bionics for cochlear implant systems.